According to a market report by Lucintel, the future of the global warfarin market looks promising with opportunities in the mechanical heart valves replacement, atrial fibrillation, deep vein thrombosis, and pulmonary embolism markets. The global warfarin market is expected to reach an estimated $8 billion by 2035 with a CAGR of 5.1% from 2026 to 2035. The major drivers for this market are the increasing prevalence of cardiovascular disorders, the rising incidence of atrial fibrillation, and the growing demand for anticoagulant therapies.
A more
than 150-page report to understand trends, opportunity and forecast in global warfarin
market to 2035 by type (1mg/tablet, 2.5mg/tablet, 3mg/tablet, 5mg/tablet, and
others), application (mechanical heart valves replacement, atrial fibrillation,
deep vein thrombosis, pulmonary embolism, and others), and region (North
America, Europe, Asia Pacific, and the Rest of the World).
Lucintel
forecasts that, within the type category, 5mg/tablet is expected to witness the
highest growth over the forecast period.
Within the
application category, atrial fibrillation is expected to witness the highest
growth.
Download
sample by clicking on warfarin market.
In terms
of region, APAC is expected to witness the highest growth over the forecast
period.
Qilu
Pharma, Sine Pharma, Beijing Jialin Pharmaceutical, Henan Zhongjie Pharma,
Shanghai Xudong Haipu Pharmaceutical, Amneal Pharma, TEVA, Cipla, Orion
Corporation Orion Pharma, BRISTOL MYERS SQUIBB are the major suppliers in the warfarin market.
This unique research
report will enable you to make confident business decisions in this globally
competitive marketplace. For a detailed table of contents, contact Lucintel at
+1-972-636-5056 or write us at helpdesk@lucintel.com. To get access of more than 1000 reports at fraction of cost
visit Lucintel's Analytics
Dashboard.
About Lucintel
At Lucintel, we offer solutions for
you growth through game changer ideas and robust market &
unmet needs analysis. We are based in
Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20
years. We are quoted in several publications like the Wall Street Journal,
ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1-972-636-5056
Explore Our Latest Publications
Data Center Managed Service Market
No comments:
Post a Comment